Validación argentino-chilena de la versión en español del test Addenbrooke's Cognitive Examination III para el diagnóstico de demencia

Abstract

This study shows that the Spanish-language version of ACE-III continues to be an effective tool for detecting cognitive dysfunction in patients with dementia.

Systematic Review of the Diagnostic Validity of Brief Cognitive Screenings for Early Dementia Detection in Spanish-Speaking Adults in Latin America

“…Administration is not standardized; the cultural and socioeconomic characteristics of the patient may bias scores, and the tool can detect dementia only in individuals with at least 5 years of education; the tool does not measure executive function; finally, the MMSE can only detect moderate or advanced dementia, and is not sensitive to early-stage Alzheimer's disease dementia (ADD) or non-Alzheimer's dementias (Dubois et al, 2000 ). Recently, other BCSs have been proposed as substitutes, such as the Montreal cognitive assessment (MoCA) (Gómez et al, 2013 ; Pereira-Manrique and Reyes, 2013 ; Gil et al, 2014 ; Pedraza et al, 2016 ; Aguilar-Navarro et al, 2017 ; Delgado et al, 2017 ), Addenbrooke's cognitive examination (ACE) (Sarasola et al, 2005 ; Custodio et al, 2012 ; Herrera-Pérez et al, 2013 ), ACE-III (Bruno et al, 2017 ), and Addenbrooke's cognitive examination-revised (ACE-R) (Torralva et al, 2011 ; Muñoz-Neira et al, 2012a ; Ospina, 2015 ), as well as complimentary tools designed to measure specific domains such as the memory alteration test (M@T) (Custodio et al, 2014 , 2017a ), INECO frontal screening (IFS) (Torralva et al, 2009 ; Ihnen Jory et al, 2013 ; Custodio et al, 2016 ), and frontal assessment battery (FAB; Dubois et al, 2000 ).…”

Propiedades Psicométricas del Addenbrooke's Cognitive Examination III: Estructura Factorial, Análisis TRI y Utilidad Diagnóstica para la detección de demencia en Atención Primaria de Salud

“…El Addenbrooke's Cognitive Examination (ACE) es la prueba que ha mostrado consistentemente mayor sensibilidad y valor predictivo para detectar demencias en etapa temprana, mostrando evidencias de validez en diversos contextos clínicos y socioculturales [18][19][20] . Su tercera versión (ACE-III) presenta diversas ventajas, de las que se destacan: propiedades psicométricas adecuadas para la detección de la disfunción cognitiva en dos de los trastornos demenciales de mayor prevalencia 21 ; niveles de sensibilidad y especificidad superiores a MMSE, ACE-R, MoCA y RUDAS, incluso en poblaciones con diferentes niveles educativos 22 ; mayor sensibilidad que MMSE y MoCA para detectar cambios en la actividad ocupacional 23 ; mayor capacidad discriminativa que MMSE para detectar alteraciones de los sistemas de memoria 24 y niveles de sensibilidad y especificidad adecuados para la detección de demencia de inicio temprano 25,26 .…”

<p>Addenbrooke&#39;s cognitive examination III in the diagnosis of dementia: a critical review</p>

“…In addition, the value of ACE-III for discriminating between Alzheimer’s dementia and fronto-temporal dementia has been reported 4,7,28,31. Patients with Alzheimer dementia and fronto-temporal dementia showed significant differences in the performance on the different components of the ACE: orientation, attention, and memory were worse in Alzheimer patients, while the fluency with letters, language, and names were worse in patients with fronto-temporal dementia.…”

“…Mathuranath, using the ACE and the ACE-R,1,3 translated this scoring pattern into an index that is considered useful for the differentiation of both types of dementia (the VLOM ratio). Many different researchers have shown the usefulness of the new version of the ACE 4,7,28,31…”